Home > Healthcare > Medical Devices > Diagnostic Devices > Intracranial Pressure (ICP) Monitoring Devices Market

Intracranial Pressure (ICP) Monitoring Devices Market Trends

Report ID: GMI3339
Published Date: Feb 2024
Report Format: PDF

Download Free Sample

Intracranial Pressure Monitoring Devices Market Trends

Market expansion is anticipated to be propelled by advancements in medical technologies. As, recently introduced intracranial pressure (ICP) monitoring devices are positioned to revolutionize the postoperative and critical care of patients with neurological conditions. Thus, the innovative devices provide precise measurements, allowing healthcare professionals to identify and respond promptly to changes in intracranial pressure dynamics.

The transition from static to dynamic variable monitoring techniques, coupled with advancements in minimally invasive monitoring approaches, is expected to drive market expansion in the forecast period.
For instance, in January 2023, Johnson & Johnson launched its new ICP monitoring system, the Codman MicroSensor ICP monitor. The monitor is a small, implantable ICP monitoring system that is designed to be less invasive than traditional ICP monitoring systems.
Furthermore, technological advancements in neurotech devices enhance patient care by offering more accurate, real-time monitoring capabilities, ultimately improving outcomes for individuals with neurological conditions.

Authors: Mariam Faizullabhoy , Gauri Wani

Frequently Asked Questions (FAQ) :

The market size of intracranial pressure (ICP) monitoring devices reached USD 1.7 billion in 2023 and is set to witness 6.8% CAGR from 2024 to 2032, owing to the increasing prevalence of various neurological disorders and traumatic accidents.

The invasive segment is estimated to account for USD 2.5 billion by 2032, as it allows for direct measurement of intracranial pressure, providing highly accurate and reliable data for clinical decision-making.

North America market held over USD 701.7 million in 2023, due to the growing prevalence of neurological conditions and traumatic brain injuries, coupled with advancements in medical technology.

Brain4Care Inc., CranioSense, LLC, HeadSense Medical Ltd., Integra LifeScience Holdings Corporation, Johnson & Johnson, Luciole Medical AG, Medtronic plc, Natus Medical Inc., RAUMEDIC AG, Sophysa, and Vittamed Corporation.